E-viri
PDF
Recenzirano
Odprti dostop
-
Taylor, Hugh S; Giudice, Linda C; Lessey, Bruce A; Abrao, Mauricio S; Kotarski, Jan; Archer, David F; Diamond, Michael P; Surrey, Eric; Johnson, Neil P; Watts, Nelson B; Gallagher, J. Chris; Simon, James A; Carr, Bruce; Dmowski, W. Paul; Leyland, Nicholas; Rowan, Jean P; Duan, W. Rachel; Ng, Juki; Schwefel, Brittany; Thomas, James W; Jain, Rita I; Chwalisz, Kristof
The New England journal of medicine, 07/2017, Letnik: 377, Številka: 1Journal Article
In two randomized trials, two different doses of the oral gonadotropin-releasing hormone antagonist elagolix significantly reduced endometriosis-related dysmenorrhea and nonmenstrual pelvic pain but had hypoestrogenic adverse effects.
